Cardinal Health, Inc. with ticker code (CAH) have now 15 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $129.00 and $95.00 suggesting an average analyst share price target price of $114.08. (at the time of writing). Now with the previous closing price of $104.63 and the analysts are correct then we can expect a percentage increase in value of 9.0%. There is a 50 day moving average of $100.63 and the 200 day moving average is $101.77. The total market capitalization for the company now stands at 25.55B. The stock price for the company is currently $104.90 USD
The potential market cap would be $27,857,828,295 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 46.42, revenue per share of $891.20 and a 2.92% return on assets.
Cardinal Health, Inc. is a globally integrated healthcare services and products company. The Company is focused on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and solutions. The Company’s segments include Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management.
